| Products | Targets | Indications | Rights | Pre‑clinical | IND | Phase I Clinical Trial | Phase II Clinical Trial | Phase III Clinical Trial |
|---|---|---|---|---|---|---|---|---|
|
HbEA
|
Non-Dialysis-Dependent Chronic Kidney Disease（NDD-CKD）
|
Global
|
|
|||||
|
Phase III clinical trials in China have initiated enrollment.
Phase II clinical trials in the U.S. have been completed. |
||||||||
|
HbEA
|
Dialysis-Dependent Chronic Kidney Disease（DD-CKD）
|
Global
|
|
|||||
|
Phase III clinical trials in China have started enrollment.
Phase II clinical trials in the U.S. have been completed. |
||||||||
|
HbEA
|
β-thalassemia（BTH）
|
Global
|
|
|||||
|
Phase II clinical trial in China is enrolling.
|
||||||||
|
HbEA
|
Cancer-Related Anemia(CRA)
|
Global
|
|
|||||
|
Preparing to initiate Phase II clinical trials in China
|
||||||||
|
HbEA
|
Myelodysplastic Syndromes(MDS)
|
Global
|
|
|||||
|
Phase II clinical trials and IIT studies in China are now enrolling.
|
||||||||
|
HbEA
|
Sickle Cell Disease (SCD)
|
Global
|
|
|||||
|
Preparing to initiate Phase II clinical trials in the U.S.
|
||||||||
| Products | Targets | Indications | Rights | Pre‑clinical | IND | Phase I Clinical Trial | Phase II Clinical Trial | Phase III Clinical Trial |
|---|---|---|---|---|---|---|---|---|
|
Estrogen Receptor
|
ER+/HER2- Breast Cancer
|
Global
|
|
|||||
|
Sino-US multicenter Phase I clinical trial in progress
|
||||||||
|
-
|
Renal Cell Carcinoma
|
Global
|
|
|||||
|
Preclinical Research
|
||||||||
| Products | Targets | Indications | Rights | Pre‑clinical | IND | Phase I Clinical Trial | Phase II Clinical Trial | Phase III Clinical Trial |
|---|---|---|---|---|---|---|---|---|
|
-
|
-
|
Global
|
|
|||||
|
Preclinical Research
|
||||||||
